Product image of Curosurf (Poractant Alfa) supplied by GNH India

Curosurf

Active Ingredient:
Poractant Alfa
Origin:
EU

Curosurf (Poractant Alfa)

Curosurf (Poractant Alfa) is a surfactant replacement therapy used to treat respiratory distress in premature infants. This product helps improve lung function and oxygenation, often administered via endotracheal tube.

Manufacturer / TM Owner

Chiesi Hellas S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Curosurf is primarily used to treat respiratory distress syndrome (RDS) in premature infants. This condition occurs when the lungs are not fully developed and lack sufficient surfactant, a substance that keeps the air sacs open. Curosurf works by replacing this missing surfactant, allowing the lungs to function more effectively. It is typically administered directly into the lungs via an endotracheal tube.

Side Effects

  • Curosurf helps to reduce the surface tension in the lungs, which can improve oxygenation and lung compliance. This can lead to better breathing and reduced need for mechanical ventilation in premature infants. The effects are generally observed shortly after administration.

Precautions & Warnings

  • Curosurf should be used under the supervision of a healthcare professional. It is important to follow proper administration techniques to ensure effective delivery and minimize the risk of complications. Always store Curosurf according to the manufacturer's instructions to maintain its efficacy.

Avoid Interactions

  • Curosurf is generally well-tolerated, but it is important to inform your healthcare provider about any other medications or treatments your infant is receiving. This can help avoid potential interactions and ensure the safe use of Curosurf.

Frequently Asked Questions

Curosurf is used to treat respiratory distress syndrome (RDS) in premature infants by replacing the missing surfactant in their lungs.

Curosurf is typically administered directly into the lungs via an endotracheal tube by a healthcare professional.

Curosurf helps to reduce surface tension in the lungs, improving oxygenation and lung compliance, which can lead to better breathing.

Curosurf should be used under the supervision of a healthcare professional and stored according to the manufacturer's instructions.

It is important to inform your healthcare provider about any other medications or treatments your infant is receiving to avoid potential interactions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Poractant Alfa

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT